Lucas C Mendez, Juanita Crook, Kevin Martell, Bryan Schaly, Douglas A Hoover, Aneesh Dhar, Vikram Velker, Belal Ahmad, Michael Lock, Ross Halperin, Andrew Warner, Glenn S Bauman, David P D'Souza
OBJECTIVE: The aim of this work was to evaluate the acute toxicity and quality-of-life (QOL) impact of ultrahypofractionated whole pelvis radiation therapy (WPRT) compared with conventional WPRT fractionation after high-dose-rate prostate brachytherapy (HDR-BT). METHODS AND MATERIALS: The HOPE trial is a phase 2, multi-institutional randomized controlled trial of men with prostate-confined disease and National Comprehensive Cancer Network unfavorable intermediate-, high-, or very-high-risk prostate cancer...
December 8, 2023: International Journal of Radiation Oncology, Biology, Physics